MCMC
MRNA icon

Matrix Capital Management Company’s Moderna MRNA Stock Holding History

Matrix Capital Management Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-730,000
Closed -$77.8M – 24
2024
Q1 		$77.8M Buy
730,000
+276,000
+61% +$27.8M 0.72% 13
2023
Q4 		$45.2M Buy
+454,000
New +$38.2M 0.46% 15

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Matrix Capital Management Company's MRNA Position: Q2 2024 in Review

Matrix Capital Management Company sold out of Moderna (MRNA) in Q2 2024, closing a stake of 730,000 shares — an estimated $77.8M sold.

Matrix Capital Management Company first reported a position in MRNA in Q4 2023 and held it in 2 quarters. The position peaked at $77.8M in Q1 2024. 955 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Matrix Capital Management Company reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Matrix Capital Management Company sold 730,000 Moderna shares in Q2 2024, an estimated $77.8M.
  • Matrix Capital Management Company first reported a position in Moderna in Q4 2023 and held it in 2 quarters.
  • Matrix Capital Management Company's Moderna position peaked at $77.8M in Q1 2024.
  • 955 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Matrix Capital Management Company's 13F filing for Q2 2024, filed 14 Aug 2024.